Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
O'Connor D, Valle-Inclán JE, Conde L, Bloye G, Rahman S, Costa JR, Bartram J, Adams S, Wright G, Elrick H, Wall K, Dyer S, Howell C, Jigoulina G, Herrero J, Cortes-Ciriano I, Moorman AV, Mansour MR.
O'Connor D, et al. Among authors: costa jr.
Blood. 2024 Mar 7;143(10):933-937. doi: 10.1182/blood.2023021906.
Blood. 2024.
PMID: 38194681